Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly

PURPOSE: Recent data indicate that extended dosing intervals (EDIs) with lanreotide autogel 120 mg are effective and well-received among patients with acromegaly who have achieved biochemical control with monthly injections of long-acting somatostatin analogues (SSAs). We further evaluated the effec...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Endocrine
Autori principali: Bernabéu, Ignacio, Fajardo, Carmen, Marazuela, Mónica, Cordido, Fernando, Venegas, Eva María, de Pablos-Velasco, Pedro, Maroto, Gonzalo Piedrola, Olvera, María Pilar, de Paz, Isabel Pavón, Carvalho, Davide, Romero, Carme, De la Cruz, Guillermo, Escolá, Cristina Álvarez
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7674328/
https://ncbi.nlm.nih.gov/pubmed/32725444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12020-020-02424-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi